Patents Represented by Attorney Gildo E. Fato
  • Patent number: 4187299
    Abstract: A new aminoglycoside antibiotic, Fortimicin E, is produced by fermentation of Micromonospora olivoasterospora ATCC 21819, 31009 and 31010 and isolated from the fermentation broth.
    Type: Grant
    Filed: December 21, 1977
    Date of Patent: February 5, 1980
    Assignee: Abbott Laboratories
    Inventor: Gerald G. Post
  • Patent number: 4185090
    Abstract: A bacterial endotoxin lipopolysaccharide of reduced toxicity covalently coupled to a protein antigen exhibits enhanced adjuvant effects. The coupling was affected by reaction with haloacylhalide. Lipopolysaccharide acylated with an anhydride of a dibasic acid is detoxified; in combination with endotoxin polysaccharide covalently coupled to protein antigen it developed synergistic immunogenic effects.
    Type: Grant
    Filed: June 17, 1977
    Date of Patent: January 22, 1980
    Assignee: Abbott Laboratories
    Inventor: Floyd C. McIntire
  • Patent number: 4183920
    Abstract: 4-N-Acyl, 2'-N-acyl and 4,2' -N,N' -diacylfortimicin E derivatives represented by the formula ##STR1## wherein R is hydrogen, acyl, aminoacyl, N-lower alkylamino acyl, N,N-diloweralkylaminoacyl, hydroxy-substituted aminoacyl or an amino acid residue; R.sub.1 is hydrogen, acyl, aminoacyl, N-loweralkylaminoacyl, N,N-diloweralkylaminoacyl, hydroxy-substituted aminoacyl or an amino acid residue, with the limitation that R cannot be hydrogen when R.sub.1 is hydrogen, and R.sub.1 cannot be hydrogen when R is hydrogen; the pharmaceutically acceptable salts thereof; intermediates therefor; pharmaceutical compositions; and methods of making and using the compounds. The compounds are useful as antibiotics.
    Type: Grant
    Filed: December 21, 1977
    Date of Patent: January 15, 1980
    Assignee: Abbott Laboratories
    Inventors: Paul Kurath, John S. Tadanier, Jerry R. Martin
  • Patent number: 4176191
    Abstract: This invention provides aminomethylene oxindole compounds represented by the formula ##STR1## wherein R is H or loweralkyl; R' is loweralkyl, aralkyl, or R and R' taken together form a chain of the formula--CH.sub.2 CH.sub.2 X CH.sub.2 CH.sub.2 --wherein X is CH.sub.2 or NR" where R" is loweralkyl, loweralkanoyl, aroyl, alkoxycarbonyl or aryl; and the pharmaceutically acceptable acid addition salts thereof.The compounds of this invention are useful as antihypertensive agents.
    Type: Grant
    Filed: November 6, 1978
    Date of Patent: November 27, 1979
    Assignee: Abbott Laboratories
    Inventors: Martin Winn, John J. Kyncl
  • Patent number: 4176178
    Abstract: 2-Deoxy-2'-N-acyl and alkyl fortimicin B and derivatives, 4,2'-N,N'-diacyl and dialkyl fortimicin B derivatives, 4-N-acyl-2'-N-alkyl- and 4-N-alkyl-2'-N-acyl fortimicin B derivatives represented by the formula ##STR1## wherein R is acyl, aminoacyl, N-monoloweralkylaminoacyl, N,N-diloweralkylaminoacyl, hydroxy-substituted aminoacyl, hydroxyacyl, an amino acid residue, loweralkyl, aminoloweralkyl, hydroxyloweralkyl, N-loweralkylaminoloweralkyl, N,N-diloweralkylaminoloweralkyl, aminohydroxyloweralkyl, N-loweralkylaminohydroxyloweralkyl or N,N-diloweralkylaminohydroxyloweralkyl; and R.sub.
    Type: Grant
    Filed: December 21, 1977
    Date of Patent: November 27, 1979
    Assignee: Abbott Laboratories
    Inventors: Jerry R. Martin, John S. Tadanier, Paulette Collum
  • Patent number: 4174312
    Abstract: This invention provides 4-N-acylfortimicin B derivatives of the structure ##STR1## wherein R is acyl, aminoacyl, N-monoloweralkylaminoacyl, N,N-diloweralkylaminoacyl, hydroxy-substituted aminoacyl, or substituted aminoacyl of the formula ##STR2## where R.sup.1 is an acyl radical derived from an amino acid or a short peptide, and the pharmaceutically acceptable salts thereof.The compounds are useful as intermediates for preparing 4-N-alkyl or substituted alkylfortimicin B derivatives. In addition to their utility as intermediates, some of the compounds of this invention are also useful as antimicrobial agents.
    Type: Grant
    Filed: November 1, 1978
    Date of Patent: November 13, 1979
    Assignee: Abbott Laboratories
    Inventors: John S. Tadanier, Jerry R. Martin, Paul Kurath
  • Patent number: 4173564
    Abstract: This invention provides 4-N-acylfortimicin B derivatives of the structure ##STR1## wherein R is acyl, aminoacyl, N-monoloweralkylaminoacyl, N,N-diloweralkylaminoacyl, hydroxy-substituted aminoacyl, or substituted aminoacyl of the formula ##STR2## where R.sup.1 is an acyl radical derived from an amino acid or a short peptide, and the pharmaceutically acceptable salts thereof.The compounds are useful as intermediates for preparing 4-N-alkyl or substituted alkylfortimicin B derivatives. In addition to their utility as intermediates, some of the compounds of this invention are also useful as antimicrobial agents.
    Type: Grant
    Filed: November 1, 1978
    Date of Patent: November 6, 1979
    Assignee: Abbott Laboratories
    Inventors: John S. Tadanier, Jerry R. Martin, Paul Kurath
  • Patent number: 4172943
    Abstract: A compound of the formula ##STR1## wherein R.sub.1 is H or loweralkyl; R.sub.2 is H, loweralkyl, phenyl or substituted phenyl; R is C.sub.3 -C.sub.20 alkyl, phenyl alkyl or substituted phenyl alkyl; R.sub.3 is H or ##STR2## where X is a straight or branched chain alkylene group of 3 to 4 carbon atoms, and R.sub.4 and R.sub.5 are the same or different members of the group consisting of H or loweralkyl; or R.sub.4 and R.sub.5 taken together form a 6- or 6- member heterocyclic ring and containing no more than one additional heterocyclic atom, with or without .alpha.-loweralkyl substituents, and the acid addition salts thereof.The compounds of this invention are useful as analgesics, tranquilizers, sedative-hypnotics and anti-glaucoma agents.
    Type: Grant
    Filed: August 4, 1978
    Date of Patent: October 30, 1979
    Assignee: Abbott Laboratories
    Inventors: Harold E. Zaugg, Cheuk M. Lee
  • Patent number: 4171367
    Abstract: Described are compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are hydrogen, alkyl, cycloalkyl, and aryl, R.sup.3 is hydrogen or halogen, and R.sup.4 is hydrogen or acyl, and pharmaceutically acceptable acid addition salts thereof. R.sup.3 can be located in the 4 or 5 position as can the amino imidazoline group. The compounds are useful as anti-inflammatory agents.
    Type: Grant
    Filed: February 18, 1977
    Date of Patent: October 16, 1979
    Assignee: Abbott Laboratories
    Inventors: Martin Winn, Carl W. Nordeen
  • Patent number: 4169198
    Abstract: A new fortimicin antibiotic, 2-deoxyfortimicin B, intermediates useful in the preparation of the compound, methods of making and using the compound and compositions containing 2-deoxyfortimicin B.
    Type: Grant
    Filed: December 21, 1977
    Date of Patent: September 25, 1979
    Assignee: Abbott Laboratories
    Inventors: Jerry R. Martin, John S. Tadanier, Paulette Collum
  • Patent number: 4167565
    Abstract: A method of controlling undesired animals including rodents, coyotes and birds which comprises making available to said animals an edible composition containing, as the active ingredient, a lethal dose of a compound represented by formula ##STR1## wherein R is H, loweralkyl or acetyl; R.sub.1 is H or acetyl; R.sub.2 is H, Cl or NH.sub.2 ; R.sub.3 is H, loweralkyl, alkoxy, cycloalkyl or hydroxyalkyl; R.sub.4 and R.sub.5 are each H, acetyl or propionyl, or when taken together form a p-chlorobenzylidene, a carbonate or an ethoxymethylene moiety; in a suitable carrier.
    Type: Grant
    Filed: November 8, 1976
    Date of Patent: September 11, 1979
    Assignee: Abbott Laboratories
    Inventors: Herman H. Stein, Raj N. Prasad, Karin R. Tietje, Anthony K. L. Fung
  • Patent number: 4166819
    Abstract: This invention provides 4-aroyl substituted phenoxy acetic acids and tetrazoles of the formula ##STR1## wherein R is a phenyl ring, a substituted phenyl ring, or naphthyl; R.sub.1 is --CH.sub.2 COOH or methyl tetrazole, and X.sub.1 and X.sub.2 are each a halogen or loweralkyl, or when taken together form with the two attached carbons a phenyl ring.These compounds are useful as antihypertensive agents, diuretics and uricosuric agents.
    Type: Grant
    Filed: September 6, 1977
    Date of Patent: September 4, 1979
    Assignee: Abbott Laboratories
    Inventors: Peter H. Jones, Dilbagh S. Bariana, Anthony K. L. Fung, Yvonne C. Martin, Jaroslav Kyncl, Amrit Lall
  • Patent number: 4162912
    Abstract: Disclosed is a composition and method for controlling milkweed vine by applying Araujio mosaic virus to the vine.
    Type: Grant
    Filed: February 7, 1978
    Date of Patent: July 31, 1979
    Assignee: Raghavan Charudattan
    Inventor: Raghavan Charudattan
  • Patent number: 4155902
    Abstract: This invention provides 4-N-acylfortimicin B derivatives of the structure ##STR1## wherein R is acyl, aminoacyl, N-monoloweralkylaminoacyl, N,N-diloweralkylaminoacyl, hydroxy-substituted aminoacyl, or substituted aminoacyl of the formula ##STR2## where R.sup.1 is an acyl radical derived from an amino acid or a short peptide, and the pharmaceutically acceptable salts thereof.The compounds are useful as intermediates for preparing 4-N-alkyl or substituted alkylfortimicin B derivatives. In addition to their utility as intermediates, some of the compounds of this invention are also useful as antimicrobial agents.
    Type: Grant
    Filed: March 20, 1978
    Date of Patent: May 22, 1979
    Assignee: Abbott Laboratories
    Inventors: John S. Tadanier, Jerry R. Martin, Paul Kurath
  • Patent number: 4152327
    Abstract: A compound of the formula ##STR1## wherein n is 1 or 2; R is C.sub.3 -C.sub.20 alkyl or arylalkyl; R.sub.1 is OH, loweralkoxy or NR.sub.2 R.sub.3 where R.sub.2 and R.sub.3 each are H, lower-alkyl or aryl.The compounds of this invention are useful as tranquilizers, analgesics, and sedative-hypnotics.
    Type: Grant
    Filed: April 19, 1978
    Date of Patent: May 1, 1979
    Assignee: Abbott Laboratories
    Inventors: Harold E. Zaugg, Cheuk M. Lee
  • Patent number: D251670
    Type: Grant
    Filed: June 20, 1977
    Date of Patent: April 24, 1979
    Inventors: Emil H. Soika, Robert R. Genc
  • Patent number: D251798
    Type: Grant
    Filed: February 28, 1977
    Date of Patent: May 8, 1979
    Assignee: Abbott Laboratories
    Inventor: Stephen G. Hauser
  • Patent number: D251799
    Type: Grant
    Filed: February 28, 1977
    Date of Patent: May 8, 1979
    Assignee: Abbott Laboratories
    Inventor: Stephen G. Hauser
  • Patent number: D251800
    Type: Grant
    Filed: February 28, 1977
    Date of Patent: May 8, 1979
    Assignee: Abbott Laboratories
    Inventor: Stephen G. Hauser
  • Patent number: D253785
    Type: Grant
    Filed: July 5, 1977
    Date of Patent: December 25, 1979
    Inventor: Louis V. Cook